药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cinolazepam
Metildigoxin
The risk or severity of adverse effects can be increased when Hydrocortisone butyrate is combined with Metildigoxin.
Cinolazepam
Gastric inhibitory polypeptide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Gastric inhibitory polypeptide.
Cinolazepam
Tirzepatide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Tirzepatide.
Cinolazepam
Englitazone
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Englitazone.
Cinolazepam
Taspoglutide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Taspoglutide.
Cinolazepam
Semaglutide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Semaglutide.
Cinolazepam
Metahexamide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Metahexamide.
Cinolazepam
Guar gum
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Guar gum.
Cinolazepam
Carbutamide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Carbutamide.
Cinolazepam
Remogliflozin etabonate
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Remogliflozin etabonate.
Cinolazepam
Balaglitazone
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Balaglitazone.
Cinolazepam
Sotagliflozin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Sotagliflozin.
Cinolazepam
Evogliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Evogliptin.
Cinolazepam
Anagliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Anagliptin.
Cinolazepam
Gemigliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Gemigliptin.
Cinolazepam
Carmegliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Carmegliptin.
Cinolazepam
Omarigliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Omarigliptin.
Cinolazepam
Teneligliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Teneligliptin.
Cinolazepam
2,4-thiazolidinedione
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with 2,4-thiazolidinedione.
Cinolazepam
Tofogliflozin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Tofogliflozin.